Genmab logo

Genmab Investor Relations Material

Genmab, a biotechnology company, develops antibody therapeutics for the treatment of cancer and other diseases primarily in Europe.

Upcoming events for

Q2 20222022-08-10

Latest company events

More about Genmab

Ticker symbol




Investor Relations Page

Dig deeper into the Genmab fundamentals on Quartr.

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
App store link
Android play link
Quartr app screenshot